| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c89ce4d9ac03f9acd8ddede1162f94d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 |
| filingDate |
2011-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6294e7b9e4fdfc2fbbf2e527660de65c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5db0175b50e7f07d948b919d7729c3e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_610f90cf9a51bc71327499b185e4fed3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3186a0116767428de34d47cd5ec88d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0a46971d9187cf3c825226420d92c3c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d72b11229071040e8d50032ae1807d0d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5da64e500b7371a574d897d938309e1f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_019b4c199f3bcb14325dd12ecb48a2f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a9e6336ed12f63de85447f467b62db1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f033b35c618c3f968147052f5664a843 |
| publicationDate |
2012-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2816974-A1 |
| titleOfInvention |
Piperidinone carboxamide indane cgrp receptor antagonists |
| abstract |
The present invention is directed to piperidinone carboxamide indane derivatives which are antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which the CGRP is involved, such as migraine. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved. |
| priorityDate |
2010-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |